Daniel S. Reshef

2.7k total citations
8 papers, 337 citations indexed

About

Daniel S. Reshef is a scholar working on Ophthalmology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel S. Reshef has authored 8 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Ophthalmology, 3 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel S. Reshef's work include Ophthalmology and Visual Impairment Studies (2 papers), Intraocular Surgery and Lenses (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). Daniel S. Reshef is often cited by papers focused on Ophthalmology and Visual Impairment Studies (2 papers), Intraocular Surgery and Lenses (2 papers) and Pharmacovigilance and Adverse Drug Reactions (1 paper). Daniel S. Reshef collaborates with scholars based in United States, Switzerland and Netherlands. Daniel S. Reshef's co-authors include F. Stephen Hodi, William H. Sharfman, Alexandre Avila, Sérgio Jobim Azevedo, David A. Reardon, Christopher D. Lao, Hewei Li, Bartosz Chmielowski, Karijn P.M. Suijkerbuijk and Jeffrey S. Weber and has published in prestigious journals such as Ophthalmology, The Journals of Gerontology Series A and The Oncologist.

In The Last Decade

Daniel S. Reshef

8 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel S. Reshef United States	7	180	128	91	68	52	8	337
G. Podilsky Switzerland	3	58 0.3×	53 0.4×	259 2.8×	31 0.5×	35 0.7×	3	292
Rosaria Gallucci Italy	7	150 0.8×	127 1.0×	18 0.2×	29 0.4×	46 0.9×	11	245
Greg Rossi United States	12	82 0.5×	49 0.4×	5 0.1×	179 2.6×	13 0.3×	19	581
Xiaowei Sun China	11	36 0.2×	124 1.0×	33 0.4×	5 0.1×	55 1.1×	20	355
A Lyons United Kingdom	9	40 0.2×	28 0.2×	20 0.2×	42 0.6×	28 0.5×	15	281
Scott Grant United States	6	181 1.0×	101 0.8×	100 1.1×	2 0.0×	64 1.2×	15	352
Simon Bailey United Kingdom	9	44 0.2×	21 0.2×	7 0.1×	63 0.9×	57 1.1×	22	211
Omar Lababede United States	9	85 0.5×	164 1.3×	4 0.0×	10 0.1×	43 0.8×	13	280
Raees Tonse India	10	95 0.5×	115 0.9×	2 0.0×	92 1.4×	58 1.1×	39	292

Countries citing papers authored by Daniel S. Reshef

Since Specialization

Citations

This map shows the geographic impact of Daniel S. Reshef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Reshef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Reshef more than expected).

Fields of papers citing papers by Daniel S. Reshef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Reshef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Reshef. The network helps show where Daniel S. Reshef may publish in the future.

Co-authorship network of co-authors of Daniel S. Reshef

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Reshef. A scholar is included among the top collaborators of Daniel S. Reshef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Reshef. Daniel S. Reshef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Larkin, James, Bartosz Chmielowski, Christopher D. Lao, et al.. (2017). Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis. The Oncologist. 22(6). 709–718. 205 indexed citations

2.

Hauben, Manfred, et al.. (2017). The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies. Therapeutic Advances in Drug Safety. 8(5). 145–156. 18 indexed citations

3.

Bakri, Sophie J., Darius M. Moshfeghi, Amy Chen Rundle, et al.. (2014). Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials. Ophthalmology. 121(5). 1102–1108. 71 indexed citations

4.

Lee, J. Jack, Lei Feng, Daniel S. Reshef, et al.. (2010). Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin. Cancer Prevention Research. 3(6). 738–744. 9 indexed citations

5.

Fried, Linda P., et al.. (2010). Diastolic Blood Pressure Levels and Ischemic Stroke Incidence in Older Adults With White Matter Lesions. The Journals of Gerontology Series A. 66A(1). 74–81. 10 indexed citations

6.

Reshef, Daniel S., et al.. (1997). Postoperative cataract surgery satisfaction in a rural Kenyan clinic. Journal of Cataract & Refractive Surgery. 23(4). 575–580. 11 indexed citations

7.

Reshef, Daniel S., et al.. (1987). Diagnosis and intraoperative localization of a deep orbital organic foreign body. Orbit. 6(1). 3–15. 11 indexed citations

8.

Zauberman, H., Daniel S. Reshef, & Shmuel Levinger. (1984). Streak retinoscopy during intraocular lens implantation to determine spheric power and prevent astigmatism.. PubMed. 10(1). 73–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact